Clinical Trial Update: Trifluridine/Tipiracil (TAS-102) With or Without Thalidomide for the Treatment of Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating trifluridine/tipiracil (TAS-102) with or without thalidomide for metastatic colorectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Thalidomide (thalidomide)
• trifluridine/tipiracil (trifluridine/tipiracil)

Snippet

Sponsor: Fujian Cancer Hospital | Conditions: Metastatic Colorectal Cancer | Phase 2 | Status: UNKNOWN